Aceso Trading Algorithms
Total AUM
--
across 2 strategies
Total P&L
--
all time
Combined Sharpe
--
annualized
Max Drawdown
--
worst peak-to-trough
API Calls Today
--
--
Today's API Cost
--
estimated
Month-to-Date
--
running total
→
Strategy I
--
Pre-Revenue Biotech
Maintains a basket of 15–20 clinical-stage biotechs screened by cash runway, trial phase, and catalyst proximity.
Value
--
Return
--
Sharpe
--
Medium-Term
Catalyst-Driven
Phase 2/3
→
Strategy II
--
Fundamental Quality
Selects top equities by fundamental quality — P/E, margins, revenue growth, ROE, and DCF valuation. Equal-weight, rebalanced weekly.
Value
--
Return
--
Sharpe
--
Weekly Rebalance
Value + Quality
DCF Screened